Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy

Seizure

Volumn 16, Issue 4, 2007, Pages 345-350

  Grosso, S ^a   Cordelli, D M ^a   Franzoni, E ^b   Coppola, G ^c   Capovilla, G ^d   Zamponi, N ^e   Verrotti, A ^f   Morgese, G ^a   Balestri, P ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d CARLO POMA HOSPITAL   (Italy)

^e Ospedale Pediatrico G Salesi   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

Author keywords

Antiepileptic drug; Children; Drug resistant epilepsy; Epilepsy syndromes; Levetiracetam

Indexed keywords

ETIRACETAM;

ANOREXIA; ARTICLE; COGNITIVE DEFECT; DROWSINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GRAND MAL SEIZURE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NERVOUSNESS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SLEEP DISORDER; TREATMENT DURATION; VOMITING; WEST SYNDROME;

ANTICONVULSANTS; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PIRACETAM; RETROSPECTIVE STUDIES;

EID: 34247270757     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.02.004     Document Type: Article

References (27)

1. Shorvon S.D., and van Rijckevorsel K. A new antiepileptic drug. J Neurol Neurosurg Psychiatry 72 (2002) 426-429
2. Vigevano F. Levetiracetam in pediatrics. J Child Neurol 20 (2005) 87-93
3. Niespodziany I., Klitgaard H., and Margineanu D.G. Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices. Neurosci Lett 306 (2001) 5-8
4. Rigo J.M., Hans G., Nguyen L., et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136 (2002) 659-672
5. Pellock J.M., Glauser T.A., Bebin E.M., et al. Pharmacokinetic study of levetiracetam in children. Epilepsia 42 (2001) 1574-1579
6. Ben-Menachem E., and Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia 41 (2000) 1276-1283
7. Leppik I.E., Biton V., Sander J.W., and Wieser H.G. Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials. Epilepsia 44 (2003) 1585-1587
8. Glauser T.A., Ayala R., Elterman R.D., et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66 (2006) 1654-1660
9. Commission on classification and terminology of the International League Against Epilepsy, 1981. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 (1981) 489-501
10. Commission on classification and terminology of the International League Against Epilepsy, 1989. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 (1989) 389-399
11. Engel Jr. J., and International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42 (2001) 796-803
12. Genton P., Sadzot B., Fejerman N., et al. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial. Acta Neurol Scand 113 (2006) 387-394
13. Shorvon S.D., Lowenthal A., Janz D., Bielen E., and Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia 41 (2000) 1179-1186
14. Cereghino J.J., Biton V., Abou-Khalil B., et al. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 55 (2000) 236-242
15. Glauser T.A., Pellock J.M., Bebin E.M., et al. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial. Epilepsia 43 (2002) 518-524
16. Herranz J.L., Rufo-Campos M., and Arteaga R. Effectiveness and tolerability of levetiracetam in 43 children and adolescents with epilepsy. Rev Neurol 37 (2003) 1005-1008
17. Wheless J.W., and Ng Y.T. Levetiracetam in refractory pediatric epilepsy. J Child Neurol 17 (2002) 413-415
18. De los Reyes E.C., Sharp G.B., and Hale S.E. Levetiracetam in the treatment of Lennox-Gastaut syndrome. Ann Neurol 50 Suppl. 1 (2001) S108
19. Opp J., Tuxhorn I., May T., et al. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Seizure 14 (2005) 476-484
20. Grosso S., Franzoni E., Coppola G., et al. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure 14 (2005) 248-253
21. Lagae L., Buyse G., and Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure 14 (2005) 66-71
22. Mandelbaum D.E., Bunch M., Kugler S.L., Venkatasubramanian A., and Wollack J.B. Efficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug use. J Child Neurol 20 (2005) 590-594
23. Koukkari M.W., and Guarino E.J. Retrospective study of the use of levetiracetam in childhood seizure disorders. J Child Neurol 19 (2004) 944-947
24. Lagae L., Buyse G., Deconinck A., and Ceulemans B. Effect of levetiracetam in refractory childhood epilepsy syndromes. Eur J Paediatr Neurol 7 (2003) 123-128
25. Krakow K., Walker M., Otoul C., and Sander J.W. Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology 56 (2001) 1772-1774
26. Kossoff E.H., Bergey G.K., Freeman J.M., and Vining E.P. Levetiracetam psychosis in children with epilepsy. Epilepsia 42 (2001) 1611-1613
27. Mula M., Trimble M.R., and Sander J.W. Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. Seizure 13 (2004) 55-57